Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Plantar Ulcers and Neuropathic Arthropathies: Associated Diseases, Polyneuropathy Correlates, and Risk Covariates.

Andrews KL, Dyck PJ, Kavros SJ, Vella A, Kazamel M, Clark V, Litchy WJ, Dyck PJB, Lodermeier KA, Davies JL, Carter RE, Klein CJ.

Adv Skin Wound Care. 2019 Jan 7. doi: 10.1097/01.ASW.0000550591.08674.98. [Epub ahead of print]

PMID:
30624254
2.

Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis.

Al-Sharea A, Lee MKS, Whillas A, Michell D, Shihata W, Nicholls AJ, Cooney OD, Kraakman MJ, Bertuzzo Veiga C, Jefferis AM, Jackson K, Nagareddy PR, Lambert G, Wong CHY, Andrews KL, Head GA, Chin-Dusting J, Murphy AJ.

Haematologica. 2018 Oct 25. pii: haematol.2018.192898. doi: 10.3324/haematol.2018.192898. [Epub ahead of print]

3.

Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis.

Wu B, Murray JK, Andrews KL, Sham K, Long J, Aral J, Ligutti J, Amagasu S, Liu D, Zou A, Min X, Wang Z, Ilch CP, Kornecook TJ, Lin MJ, Be X, Miranda LP, Moyer BD, Biswas K.

J Med Chem. 2018 Nov 8;61(21):9500-9512. doi: 10.1021/acs.jmedchem.8b00736. Epub 2018 Oct 22.

PMID:
30346167
4.

Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.

Khan SI, Shihata WA, Andrews KL, Lee MKS, Moore XL, Jefferis AM, Vinh A, Gaspari T, Dragoljevic D, Jennings GL, Murphy AJ, Chin-Dusting JPF.

FASEB J. 2019 Jan;33(1):1510-1521. doi: 10.1096/fj.201701498RR. Epub 2018 Aug 29.

PMID:
30156911
5.

Associations of physical activity with anxiety symptoms and status: results from The Irish longitudinal study on ageing.

McDowell CP, Gordon BR, Andrews KL, MacDonncha C, Herring MP.

Epidemiol Psychiatr Sci. 2018 Jan 31:1-10. doi: 10.1017/S204579601800001X. [Epub ahead of print]

PMID:
29382402
6.

Y-chromosome lineage determines cardiovascular organ T-cell infiltration in the stroke-prone spontaneously hypertensive rat.

Khan SI, Andrews KL, Jackson KL, Memon B, Jefferis AM, Lee MKS, Diep H, Wei Z, Drummond GR, Head GA, Jennings GL, Murphy AJ, Vinh A, Sampson AK, Chin-Dusting JPF.

FASEB J. 2018 May;32(5):2747-2756. doi: 10.1096/fj.201700933RR. Epub 2018 Jan 4.

PMID:
29301944
7.

Grasp Performance of a Soft Synergy-Based Prosthetic Hand: A Pilot Study.

Gailey AS, Godfrey SB, Breighner RE, Andrews KL, Zhao KD, Bicchi A, Santello M.

IEEE Trans Neural Syst Rehabil Eng. 2017 Dec;25(12):2407-2417. doi: 10.1109/TNSRE.2017.2737539.

PMID:
29220323
8.

Vascular dysfunction in the stroke-prone spontaneously hypertensive rat is dependent on constrictor prostanoid activity and Y chromosome lineage.

Khan SI, Andrews KL, Jefferis AM, Jennings GL, Sampson AK, Chin-Dusting JPF.

Clin Sci (Lond). 2018 Jan 16;132(1):131-143. doi: 10.1042/CS20171291. Print 2018 Jan 16.

PMID:
29162746
9.

Applications of parallel synthetic lead hopping and pharmacophore-based virtual screening in the discovery of efficient glycine receptor potentiators.

Chakka N, Andrews KL, Berry LM, Bregman H, Gunaydin H, Huang L, Guzman-Perez A, Plant MH, Simard JR, Gingras J, DiMauro EF.

Eur J Med Chem. 2017 Sep 8;137:63-75. doi: 10.1016/j.ejmech.2017.05.036. Epub 2017 May 12.

PMID:
28575722
10.

Caveolae: A Role in Endothelial Inflammation and Mechanotransduction?

Shihata WA, Michell DL, Andrews KL, Chin-Dusting JP.

Front Physiol. 2016 Dec 20;7:628. doi: 10.3389/fphys.2016.00628. eCollection 2016. Review.

11.

The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine Receptors.

Bregman H, Simard JR, Andrews KL, Ayube S, Chen H, Gunaydin H, Guzman-Perez A, Hu J, Huang L, Huang X, Krolikowski PH, Lehto SG, Lewis RT, Michelsen K, Pegman P, Plant MH, Shaffer PL, Teffera Y, Yi S, Zhang M, Gingras J, DiMauro EF.

J Med Chem. 2017 Feb 9;60(3):1105-1125. doi: 10.1021/acs.jmedchem.6b01496. Epub 2016 Dec 21.

PMID:
28001399
12.

Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.

Wurz RP, Sastri C, D'Amico DC, Herberich B, Jackson CLM, Pettus LH, Tasker AS, Wu B, Guerrero N, Lipford JR, Winston JT, Yang Y, Wang P, Nguyen Y, Andrews KL, Huang X, Lee MR, Mohr C, Zhang JD, Reid DL, Xu Y, Zhou Y, Wang HL.

Bioorg Med Chem Lett. 2016 Nov 15;26(22):5580-5590. doi: 10.1016/j.bmcl.2016.09.067. Epub 2016 Oct 1.

PMID:
27769621
13.

The Impact of the Immediate Postoperative Prosthesis on Patient Mobility and Quality of Life after Transtibial Amputation.

Samuelsen BT, Andrews KL, Houdek MT, Terry M, Shives TC, Sim FH.

Am J Phys Med Rehabil. 2017 Feb;96(2):116-119. doi: 10.1097/PHM.0000000000000553.

PMID:
27386805
14.

Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.

Pettus LH, Andrews KL, Booker SK, Chen J, Cee VJ, Chavez F Jr, Chen Y, Eastwood H, Guerrero N, Herberich B, Hickman D, Lanman BA, Laszlo J 3rd, Lee MR, Lipford JR, Mattson B, Mohr C, Nguyen Y, Norman MH, Powers D, Reed AB, Rex K, Sastri C, Tamayo N, Wang P, Winston JT, Wu B, Wu T, Wurz RP, Xu Y, Zhou Y, Tasker AS, Wang HL.

J Med Chem. 2016 Jul 14;59(13):6407-30. doi: 10.1021/acs.jmedchem.6b00610. Epub 2016 Jun 22.

PMID:
27285051
15.

Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarization.

Andrews KL, Sampson AK, Irvine JC, Shihata WA, Michell DL, Lumsden NG, Lim C, Huet O, Drummond GR, Kemp-Harper BK, Chin-Dusting JP.

Clin Sci (Lond). 2016 Sep 1;130(18):1629-40. doi: 10.1042/CS20160097. Epub 2016 May 26.

PMID:
27231254
16.

Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors.

Cee VJ, Chavez F Jr, Herberich B, Lanman BA, Pettus LH, Reed AB, Wu B, Wurz RP, Andrews KL, Chen J, Hickman D, Laszlo J 3rd, Lee MR, Guerrero N, Mattson BK, Nguyen Y, Mohr C, Rex K, Sastri CE, Wang P, Wu Q, Wu T, Xu Y, Zhou Y, Winston JT, Lipford JR, Tasker AS, Wang HL.

ACS Med Chem Lett. 2016 Feb 12;7(4):408-12. doi: 10.1021/acsmedchemlett.5b00403. eCollection 2016 Apr 14.

17.

Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.

Murray JK, Long J, Zou A, Ligutti J, Andrews KL, Poppe L, Biswas K, Moyer BD, McDonough SI, Miranda LP.

J Med Chem. 2016 Mar 24;59(6):2704-17. doi: 10.1021/acs.jmedchem.5b01947. Epub 2016 Mar 10.

PMID:
26890998
18.

Multisite tyrosine phosphorylation of the N-terminus of Mint1/X11α by Src kinase regulates the trafficking of amyloid precursor protein.

Dunning CJ, Black HL, Andrews KL, Davenport EC, Conboy M, Chawla S, Dowle AA, Ashford D, Thomas JR, Evans GJ.

J Neurochem. 2016 May;137(4):518-27. doi: 10.1111/jnc.13571. Epub 2016 Mar 1.

19.

Native LDL promotes differentiation of human monocytes to macrophages with an inflammatory phenotype.

Al-Sharea A, Lee MK, Moore XL, Fang L, Sviridov D, Chin-Dusting J, Andrews KL, Murphy AJ.

Thromb Haemost. 2016 Apr;115(4):762-72. doi: 10.1160/TH15-07-0571. Epub 2015 Dec 17.

PMID:
26676845
20.

Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational Constraint.

Pennington LD, Bartberger MD, Croghan MD, Andrews KL, Ashton KS, Bourbeau MP, Chen J, Chmait S, Cupples R, Fotsch C, Helmering J, Hong FT, Hungate RW, Jordan SR, Kong K, Liu L, Michelsen K, Moyer C, Nishimura N, Norman MH, Reichelt A, Siegmund AC, Sivits G, Tadesse S, Tegley CM, Van G, Yang KC, Yao G, Zhang J, Lloyd DJ, Hale C, St Jean DJ Jr.

J Med Chem. 2015 Dec 24;58(24):9663-79. doi: 10.1021/acs.jmedchem.5b01367. Epub 2015 Dec 1.

21.

Oxopyrido[2,3-d]pyrimidines as Covalent L858R/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors.

Wurz RP, Pettus LH, Ashton K, Brown J, Chen JJ, Herberich B, Hong FT, Hu-Harrington E, Nguyen T, St Jean DJ Jr, Tadesse S, Bauer D, Kubryk M, Zhan J, Cooke K, Mitchell P, Andrews KL, Hsieh F, Hickman D, Kalyanaraman N, Wu T, Reid DL, Lobenhofer EK, Andrews DA, Everds N, Guzman R, Parsons AT, Hedley SJ, Tedrow J, Thiel OR, Potter M, Radinsky R, Beltran PJ, Tasker AS.

ACS Med Chem Lett. 2015 Jul 27;6(9):987-92. doi: 10.1021/acsmedchemlett.5b00193. eCollection 2015 Sep 10.

22.

The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors.

Stec MM, Andrews KL, Bo Y, Caenepeel S, Liao H, McCarter J, Mullady EL, San Miguel T, Subramanian R, Tamayo N, Whittington DA, Wang L, Wu T, Zalameda LP, Zhang N, Hughes PE, Norman MH.

Bioorg Med Chem Lett. 2015 Oct 1;25(19):4136-42. doi: 10.1016/j.bmcl.2015.08.016. Epub 2015 Aug 8.

PMID:
26298499
23.

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.

Murray JK, Qian YX, Liu B, Elliott R, Aral J, Park C, Zhang X, Stenkilsson M, Salyers K, Rose M, Li H, Yu S, Andrews KL, Colombero A, Werner J, Gaida K, Sickmier EA, Miu P, Itano A, McGivern J, Gegg CV, Sullivan JK, Miranda LP.

J Med Chem. 2015 Sep 10;58(17):6784-802. doi: 10.1021/acs.jmedchem.5b00495. Epub 2015 Aug 31.

PMID:
26288216
24.

Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.

Murray JK, Biswas K, Holder JR, Zou A, Ligutti J, Liu D, Poppe L, Andrews KL, Lin FF, Meng SY, Moyer BD, McDonough SI, Miranda LP.

Bioorg Med Chem Lett. 2015 Nov 1;25(21):4866-4871. doi: 10.1016/j.bmcl.2015.06.033. Epub 2015 Jun 16.

PMID:
26112439
25.

Wrestlers with Limb Deficiencies: A Descriptive Study.

Baria MR, Terry MJ, Driscoll SW, Andrews KL, Soma DB, Prideaux CC.

Am J Phys Med Rehabil. 2015 Dec;94(12):1052-7. doi: 10.1097/PHM.0000000000000295.

PMID:
25888658
26.

Prosthetic Rehabilitation After Hip Disarticulation or Hemipelvectomy.

Kralovec ME, Houdek MT, Andrews KL, Shives TC, Rose PS, Sim FH.

Am J Phys Med Rehabil. 2015 Dec;94(12):1035-40. doi: 10.1097/PHM.0000000000000292.

PMID:
25888656
27.

Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.

Joshi MS, Williams D, Horlock D, Samarasinghe T, Andrews KL, Jefferis AM, Berger PJ, Chin-Dusting JP, Kaye DM.

Diab Vasc Dis Res. 2015 May;12(3):208-16. doi: 10.1177/1479164114565629. Epub 2015 Mar 12.

PMID:
25767181
28.

Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.

Andrews KL, Lumsden NG, Farry J, Jefferis AM, Kemp-Harper BK, Chin-Dusting JP.

Clin Sci (Lond). 2015 Jul;129(2):179-87. doi: 10.1042/CS20140759.

PMID:
25728899
29.

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.

Murray JK, Ligutti J, Liu D, Zou A, Poppe L, Li H, Andrews KL, Moyer BD, McDonough SI, Favreau P, Stöcklin R, Miranda LP.

J Med Chem. 2015 Mar 12;58(5):2299-314. doi: 10.1021/jm501765v. Epub 2015 Feb 19.

PMID:
25658507
30.

Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors.

Wu B, Wang HL, Cee VJ, Lanman BA, Nixey T, Pettus L, Reed AB, Wurz RP, Guerrero N, Sastri C, Winston J, Lipford JR, Lee MR, Mohr C, Andrews KL, Tasker AS.

Bioorg Med Chem Lett. 2015 Feb 15;25(4):775-80. doi: 10.1016/j.bmcl.2014.12.091. Epub 2015 Jan 7.

PMID:
25616902
31.

Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine.

Andrews KL, Houdek MT, Kiemele LJ.

Prosthet Orthot Int. 2015 Feb;39(1):29-39. doi: 10.1177/0309364614534296. Review.

PMID:
25614499
32.

Guest editorial.

Andrews KL.

Prosthet Orthot Int. 2015 Feb;39(1):6. doi: 10.1177/0309364614565576. No abstract available.

PMID:
25614496
33.

The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors.

Wurz RP, Pettus LH, Jackson C, Wu B, Wang HL, Herberich B, Cee V, Lanman BA, Reed AB, Chavez F Jr, Nixey T, Laszlo J 3rd, Wang P, Nguyen Y, Sastri C, Guerrero N, Winston J, Lipford JR, Lee MR, Andrews KL, Mohr C, Xu Y, Zhou Y, Reid DL, Tasker AS.

Bioorg Med Chem Lett. 2015 Feb 15;25(4):847-55. doi: 10.1016/j.bmcl.2014.12.067. Epub 2015 Jan 7.

PMID:
25599837
34.

The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.

Wang HL, Cee VJ, Chavez F Jr, Lanman BA, Reed AB, Wu B, Guerrero N, Lipford JR, Sastri C, Winston J, Andrews KL, Huang X, Lee MR, Mohr C, Xu Y, Zhou Y, Tasker AS.

Bioorg Med Chem Lett. 2015 Feb 15;25(4):834-40. doi: 10.1016/j.bmcl.2014.12.068. Epub 2014 Dec 30.

PMID:
25597005
35.

Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability.

Harrington PE, Biswas K, Malwitz D, Tasker AS, Mohr C, Andrews KL, Dellamaggiore K, Kendall R, Beckmann H, Jaeckel P, Materna-Reichelt S, Allen JR, Lipford JR.

ACS Med Chem Lett. 2014 Sep 24;6(1):68-72. doi: 10.1021/ml500315b. eCollection 2015 Jan 8.

36.

Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).

Smith AL, Andrews KL, Beckmann H, Bellon SF, Beltran PJ, Booker S, Chen H, Chung YA, D'Angelo ND, Dao J, Dellamaggiore KR, Jaeckel P, Kendall R, Labitzke K, Long AM, Materna-Reichelt S, Mitchell P, Norman MH, Powers D, Rose M, Shaffer PL, Wu MM, Lipford JR.

J Med Chem. 2015 Feb 12;58(3):1426-41. doi: 10.1021/jm5017494. Epub 2015 Jan 14.

PMID:
25587754
37.

Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511.

Lanman BA, Reed AB, Cee VJ, Hong FT, Pettus LH, Wurz RP, Andrews KL, Jiang J, McCarter JD, Mullady EL, San Miguel T, Subramanian R, Wang L, Whittington DA, Wu T, Zalameda L, Zhang N, Tasker AS, Hughes PE, Norman MH.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5630-5634. doi: 10.1016/j.bmcl.2014.10.085. Epub 2014 Nov 1.

PMID:
25466188
38.

Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility.

Rzasa RM, Frohn MJ, Andrews KL, Chmait S, Chen N, Clarine JG, Davis C, Eastwood HA, Horne DB, Hu E, Jones AD, Kaller MR, Kunz RK, Miller S, Monenschein H, Nguyen T, Pickrell AJ, Porter A, Reichelt A, Zhao X, Treanor JJS, Allen JR.

Bioorg Med Chem. 2014 Dec 1;22(23):6570-6585. doi: 10.1016/j.bmc.2014.10.013.

PMID:
25456383
39.

Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive rats.

Sampson AK, Andrews KL, Graham D, McBride MW, Head GA, Thomas MC, Chin-Dusting JP, Dominiczak AF, Jennings GL.

Hypertension. 2014 Dec;64(6):1376-83. doi: 10.1161/HYPERTENSIONAHA.114.03756. Epub 2014 Sep 8.

PMID:
25201895
40.

Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A).

Hu E, Chen N, Bourbeau MP, Harrington PE, Biswas K, Kunz RK, Andrews KL, Chmait S, Zhao X, Davis C, Ma J, Shi J, Lester-Zeiner D, Danao J, Able J, Cueva M, Talreja S, Kornecook T, Chen H, Porter A, Hungate R, Treanor J, Allen JR.

J Med Chem. 2014 Aug 14;57(15):6632-41. doi: 10.1021/jm500713j. Epub 2014 Aug 4.

PMID:
25062128
41.

Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression.

Woollard KJ, Lumsden NG, Andrews KL, Aprico A, Harris E, Irvine JC, Jefferis AM, Fang L, Kanellakis P, Bobik A, Chin-Dusting JP.

PLoS One. 2014 May 20;9(5):e97422. doi: 10.1371/journal.pone.0097422. eCollection 2014.

42.

Core structure of the U6 small nuclear ribonucleoprotein at 1.7-Å resolution.

Montemayor EJ, Curran EC, Liao HH, Andrews KL, Treba CN, Butcher SE, Brow DA.

Nat Struct Mol Biol. 2014 Jun;21(6):544-51. doi: 10.1038/nsmb.2832. Epub 2014 May 18.

43.

Asthma self management in adults: a review of current literature.

Andrews KL, Jones SC, Mullan J.

Collegian. 2014;21(1):33-41. Review.

PMID:
24772988
44.

Hemipelvectomy: high-level amputation surgery and prosthetic rehabilitation.

Houdek MT, Kralovec ME, Andrews KL.

Am J Phys Med Rehabil. 2014 Jul;93(7):600-8. doi: 10.1097/PHM.0000000000000068. Review.

PMID:
24508940
45.

Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept.

Ashton KS, Andrews KL, Bryan MC, Chen J, Chen K, Chen M, Chmait S, Croghan M, Cupples R, Fotsch C, Helmering J, Jordan SR, Kurzeja RJ, Michelsen K, Pennington LD, Poon SF, Sivits G, Van G, Vonderfecht SL, Wahl RC, Zhang J, Lloyd DJ, Hale C, St Jean DJ Jr.

J Med Chem. 2014 Jan 23;57(2):309-24. doi: 10.1021/jm4016735. Epub 2014 Jan 9. Erratum in: J Med Chem. 2014 Mar 27;57(6):2820. Bryan, Marion C [corrected to Bryan, Marian C].

PMID:
24405172
46.

Prosthetic fitting after rotationplasty of the knee.

So NF, Andrews KL, Anderson K, Gozola MA, Shives TC, Rose PS, Shaughnessy WJ, Sim FH.

Am J Phys Med Rehabil. 2014 Apr;93(4):328-34. doi: 10.1097/PHM.0000000000000044.

PMID:
24398578
47.

Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.

Lloyd DJ, St Jean DJ Jr, Kurzeja RJ, Wahl RC, Michelsen K, Cupples R, Chen M, Wu J, Sivits G, Helmering J, Komorowski R, Ashton KS, Pennington LD, Fotsch C, Vazir M, Chen K, Chmait S, Zhang J, Liu L, Norman MH, Andrews KL, Bartberger MD, Van G, Galbreath EJ, Vonderfecht SL, Wang M, Jordan SR, Véniant MM, Hale C.

Nature. 2013 Dec 19;504(7480):437-40. doi: 10.1038/nature12724. Epub 2013 Nov 13.

PMID:
24226772
48.

Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome.

Lumsden NG, Andrews KL, Bobadilla M, Moore XL, Sampson AK, Shaw JA, Mizrahi J, Kaye DM, Dart AM, Chin-Dusting JP.

Diab Vasc Dis Res. 2013 Jul;10(4):368-74. doi: 10.1177/1479164113482593. Epub 2013 May 14.

PMID:
23673378
49.

NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.

Gray SP, Di Marco E, Okabe J, Szyndralewiez C, Heitz F, Montezano AC, de Haan JB, Koulis C, El-Osta A, Andrews KL, Chin-Dusting JP, Touyz RM, Wingler K, Cooper ME, Schmidt HH, Jandeleit-Dahm KA.

Circulation. 2013 May 7;127(18):1888-902. doi: 10.1161/CIRCULATIONAHA.112.132159. Epub 2013 Apr 5.

PMID:
23564668
50.

Noninvasive arterial studies including transcutaneous oxygen pressure measurements with the limbs elevated or dependent to predict healing after partial foot amputation.

Andrews KL, Dib MY, Shives TC, Hoskin TL, Liedl DA, Boon AJ.

Am J Phys Med Rehabil. 2013 May;92(5):385-92. doi: 10.1097/PHM.0b013e3182876a06.

PMID:
23478457

Supplemental Content

Loading ...
Support Center